1. Home
  2. NNNN vs ULCC Comparison

NNNN vs ULCC Comparison

Compare NNNN & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$23.79

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Frontier Group Holdings Inc.

ULCC

Frontier Group Holdings Inc.

HOLD

Current Price

$3.54

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNNN
ULCC
Founded
2021
1994
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.2B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
NNNN
ULCC
Price
$23.79
$3.54
Analyst Decision
Hold
Analyst Count
0
10
Target Price
N/A
$5.06
AVG Volume (30 Days)
26.3K
4.5M
Earning Date
04-28-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,724,000,000.00
Revenue This Year
N/A
$21.54
Revenue Next Year
N/A
$12.20
P/E Ratio
$446.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.91
$2.89
52 Week High
$55.65
$6.66

Technical Indicators

Market Signals
Indicator
NNNN
ULCC
Relative Strength Index (RSI) 52.80 41.14
Support Level $19.53 $3.14
Resistance Level $30.70 $4.17
Average True Range (ATR) 1.97 0.20
MACD 0.41 0.08
Stochastic Oscillator 84.48 63.45

Price Performance

Historical Comparison
NNNN
ULCC

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About ULCC Frontier Group Holdings Inc.

Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. Majority of revenue is from Domestic flight follow by International.

Share on Social Networks: